St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Also called: LFS
Li-Fraumeni Syndrome (LFS) is a rare genetic disorder that increases a person’s risk of developing 1 or more cancers at some point in their life. This condition can be passed down from parents to their children (inherited).
LFS can cause a variety of cancers. It is hard to tell what kind of cancers may happen, where in the body, or when they will occur. We do know that:
People with LFS may get cancer in their:
Less commonly, people with LFS can develop cancers in other parts of the body such as the:
LFS is caused by changes in a gene known as TP53. This gene carries important information that controls cell growth and function. A change that causes the gene to not work correctly is called a mutation.
Everyone has 2 copies of the TP53 gene. Children without this disorder carry 2 normal copies of the TP53 gene in their cells. One copy of TP53 is inherited from the child’s mother, and the other comes from the child’s father.
Children who do have LFS have 1 TP53 gene with a mutation. This mutation makes it harder for the cells to control their growth and function. The other copy of the TP53 gene may be lost or changed in cells. When this happens, cancers may develop.
Most children with LFS inherit the syndrome from 1 parent who also has LFS. However, some may develop a new TP53 mutation that did not appear to come from either parent. These children are the first in their families to have LFS.
No matter how people with LFS get their TP53 mutation, they have up to a 50% (1 in 2) chance of passing it on to their children.
A health care provider may suspect that your child has LFS after studying their medical and family cancer history.
This information helps the health care provider and the genetic counselor know if:
Your provider or genetics counselor may recommend TP53 genetic testing if they suspect LFS.
Learn more about types of genetic tests.
A blood sample is sent to a genetic testing lab. The lab runs genetic tests that looks for changes in the TP53 gene.
If your child has a TP53 mutation, the genetic counselor will work with your family to:
Parents may choose to do prenatal testing to find out if a pregnancy is affected with a known TP53 mutation. Testing may take place either before pregnancy occurs or during pregnancy.
You should work with a genetic counselor to review the pros and cons of the test. The genetic counselor can also help you prepare for the test results.
Testing before pregnancy is called preimplantation genetic testing (PGT). This special type of genetic testing is done along with in vitro fertilization (IVF). PGT tests embryos for a known TP53 mutation before a provider places the embryo into the uterus.
Testing during pregnancy can help providers see if a pregnancy has a known TP53 mutation. A doctor gathers cells from the pregnancy in 1 of 2 ways:
After tissue collection, the lab checks the sample for the TP53 mutation. Both tests carry minor risks. Discuss risks with an experienced health care provider or a genetic counselor.
Take time to think carefully about the benefits and risks of genetic testing. Speak with a genetic counselor before testing. If you decide to get tested, talk with your health care provider or a genetic counselor about your results so you can understand what they mean.
Sometimes, children or adults with LFS feel sad, anxious or angry after getting their test results. Parents may feel guilty if they pass the TP53 gene mutation to 1 or more of their children. People with a TP53 gene mutation may also have trouble getting disability or life insurance.
Read more about genetic discrimination.
Monitoring and follow-up care for LFS depends on the location of tumors that may arise and a person’s overall health. Care may involve managing symptoms and surgical removal of any cancerous tissues or tumors. It may also include other treatments like chemotherapy to fight cancers.
Radiation therapy may be necessary for certain cancers but should be avoided when possible for LFS patients.
Because Li-Fraumeni is a complex syndrome, you should discuss screening options for your child with an experienced health care provider who knows this condition well. It is important to find an experienced health care provider for your child.
Studies suggest that close monitoring LFS patients for cancer is helpful. It is recommended that children and adults with LFS be watched closely for any cancer signs or symptoms. They should seek medical treatment if they notice symptoms. When cancer is detected early, it is easier to treat it.
Talk to a health care provider who is familiar with LFS about what cancer screening tests are needed. These tests may include:
Adults with LFS may do some of the same tests. They may also need:
People with LFS have a higher cancer risk. They should monitor their health and adopt healthy habits throughout their lifetime.
Habits that will help you maintain a healthy lifestyle include:
The St. Jude Cancer Predisposition Program is dedicated to diagnosing and screening children with a genetic predisposition for cancer. Our program offers the best clinical care possible. We engage in cutting-edge research to gain more information about genetic disorders and cancer, and to improve the care and treatment for patients who are affected by these conditions. Learn more about the Division of Cancer Predisposition at St. Jude.
Our genetic counselors, clinicians, genetics nurse practitioners, and research assistants work together to provide patients with:
LFS increases your child’s risk for many types of cancer.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults who have cancers associated with LFS.
Learn more about clinical research at St. Jude.
Study goal:
To learn more about participants beliefs, attitudes, and questions about gene therapy to help make web-based resources to share information. This could help patients make treatment decisions.
Age:
18 to 35 years old with rare genetic diseases
Study goal:
The main goal of this study is to learn more about the reasons childhood tumors form and how to treat them better.
Study goal:
To provide a high-quality repository of tumor and normal samples to facilitate translational research performed by St Jude faculty and their collaborators
Study goal:
1) Test each patient for hundreds of gene variations that might be important for drug use. All of the gene test results will be in the research laboratory, but as time goes on, the study will evaluate scientific evidence and selectively move test results for a few genes into the medical record if the evidence strongly shows that the result can help in better prescribing of drugs for patients; 2) Estimate how often pharmacogenetic test results are moved from research tests into a patient’s medical record; 3) Use methods to choose which of these tests should be put in the medical record; 4) Use computer-based tools in the electronic medical record to help doctors use gene test results when prescribing drugs; 5) Share feelings and concerns of patients and their families about gene test information being put in their medical record.
Study goal:
The main purpose of this trial is to learn about the genetic causes of cancer.
Age:
Younger than 50 years old
Study goal:
To collect data about how Friedreich’s ataxia progresses over time and affects the daily life of patients.
Age:
Any
Study goal:
To find out how much patients with hemophilia B, their caregivers, and health care workers know about gene therapy for this disease, and how they feel about gene therapy. This will help us better educate patients and caregivers about gene therapy for hemophilia B.
Age:
12 years and older
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
If you have questions about the Genetic Predisposition Clinic and care for Li-Fraumeni Syndrome, email our team at GPTeam@stjude.org.